The CHU de La Réunion has launched a new interventional rhythmology service at its Nord site in Saint-Denis to treat cardiac arrhythmias [1].
This expansion provides patients with specialized medical interventions and lifestyle guidance to manage heart-rate disorders, reducing the need for travel to other regions for critical care.
The facility performed its first interventional ablation procedures for heart flutter on April 28, 2026 [3]. Ablation is a medical procedure used to treat arrhythmias by neutralizing the tissue causing irregular heartbeats. Alongside these clinical interventions, medical teams are providing advice on managing triggers that cause the heart to race, such as stress and caffeine consumption [1, 2].
Public health guidance emphasizes the role of lifestyle in heart health. Some individuals may experience "holiday-heart" syndrome, where seasonal triggers contribute to palpitations [1, 6]. Experts said that a typical resting heart rate ranges from 60 to 100 beats per minute [2], while a healthy heart beats approximately 115,000 times per day [2].
While lifestyle changes and ablation help many patients, some rhythm disorders require more advanced technology. Traditional treatment often involves implantable pacemakers and defibrillators for life-threatening cases. However, new research is exploring non-invasive alternatives. A study published on June 12, 2026, demonstrated an external pacemaker that uses ultrasound to regulate heart rhythm without the need for surgical implantation [5].
Medical resources, including reports from MSN, said there are 10 primary causes of heart-rate acceleration and 10 specific ways to slow the heart rate down through behavioral changes [4]. These include managing stress, and avoiding specific stimulants to maintain a stable cardiac rhythm.
“The CHU de La Réunion performed its first interventional ablation procedures for heart flutter on April 28, 2026.”
The integration of interventional ablation at the CHU de La Réunion, combined with the emergence of ultrasound-driven external pacemakers, signals a shift toward more localized and less invasive cardiac care. By addressing both the behavioral triggers of arrhythmias and the physiological causes through medical technology, healthcare providers are moving toward a hybrid model of prevention and high-tech intervention.
